N-Ethyl-3-hydroxynaphthalene-2-carboximidic acid | 5272-85-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-Ethyl-3-hydroxynaphthalene-2-carboximidic acid
• 英文别名: N-ethyl-3-hydroxynaphthalene-2-carboxamide
• CAS: 5272-85-5；6272-12-4
• 化学式: C₁₃H₁₃NO₂
• mdl: MFCD12144065
• 分子量: 215.25
• InChiKey: AWLIVDSCPPTBKR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.153
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• DEVELOPER CARRYING MEMBER, PROCESS FOR ITS PRODUCTION, AND DEVELOPING ASSEMBLY
  申请人：CANON KABUSHIKI KAISHA

  公开号：US20130188999A1

  公开（公告）日：2013-07-25

  A developer carrying member is provided the surface layer of which can make a developer stable by controlling its triboelectric charging strongly and which can maintain a high image quality over a long period of time even where a developer made highly spherical-particle or a small-particle developer is used. The developer carrying member has a substrate and a surface layer. The surface layer is a cured product of a resin composition containing a binder resin, conductive particles, a quaternary ammonium salt and an azo metal complex compound, the binder resin has in the molecular structure at least one structure selected from the group consisting of an —NH 2 group, an ═NH group and an —NH— linkage, and the azo metal complex compound is a compound represented by the formula ( 1 ) as defined in the specification.
• MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT
  申请人：The University of Kansas

  公开号：US20170144965A1

  公开（公告）日：2017-05-25

  A pharmaceutical composition can include: a marmelin analog compound, and a pharmaceutically acceptable carrier having the compound. The compound can be present in a therapeutically effective amount to treat or inhibit a disease state. The disease state can be cancer. The cancer can be selected from brain cancers, head and neck cancers, thyroid cancers, gastrointestinal cancers, esophageal cancers, stomach cancers, pancreatic cancers, liver cancers, colo-rectal cancers, lung cancers, kidney cancers, prostate cancers, bladder cancers, testicular cancers, breast cancers, ovarian cancers, cervical cancers, and melanomas. The carrier includes a cyclodextrin, which may form a complex with the compound. The compounds and compositions can be used to treat or inhibit progression of cancers. Colorectal, bladder, and prostate cancers are examples of some of the cancers that can be treated with the marmelin analog compounds.
• US4097475A
  申请人：——

  公开号：US4097475A

  公开（公告）日：1978-06-27
• US4400458A
  申请人：——

  公开号：US4400458A

  公开（公告）日：1983-08-23
• US8461351B2
  申请人：——

  公开号：US8461351B2

  公开（公告）日：2013-06-11